Suppression of SARS‐CoV‐2 infection in ex‐vivo human lung tissues by targeting class III phosphoinositide 3‐kinase
Chun‐Kit Yuen(University of Hong Kong), Kin‐Hang Kok(University of Hong Kong), Hin Chu(HKU-Pasteur Research Pole), Long‐Fung Mak(University of Hong Kong), Xiaohui Wang(First Affiliated Hospital Zhejiang University), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Wan‐Man Wong(University of Hong Kong)
Cited by 49
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k